|
CENPE expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.63220003968468E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.982000E-04 |
| Normal-vs-Stage2 |
1.799110E-04 |
| Normal-vs-Stage3 |
1.34659999995179E-06 |
| Normal-vs-Stage4 |
1.51719999996747E-06 |
| Stage1-vs-Stage2 |
9.600000E-02 |
| Stage1-vs-Stage3 |
8.038800E-03 |
| Stage1-vs-Stage4 |
4.425800E-04 |
| Stage2-vs-Stage3 |
5.028400E-01 |
| Stage2-vs-Stage4 |
1.584430E-02 |
| Stage3-vs-Stage4 |
4.355600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.7756000548228E-09 |
| Normal-vs-AfricanAmerican |
9.084100E-03 |
| Normal-vs-Asian |
2.877800E-01 |
| Caucasian-vs-AfricanAmerican |
2.825900E-02 |
| Caucasian-vs-Asian |
5.893400E-01 |
| AfricanAmerican-vs-Asian |
4.406000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.68950000842972E-09 |
| Normal-vs-Female |
1.53179999999864E-05 |
| Male-vs-Female |
2.951400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.464200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.83409999998663E-06 |
| Normal-vs-Age(61-80Yrs) |
6.10289999647406E-08 |
| Normal-vs-Age(81-100Yrs) |
9.807800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.155000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.136600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.631400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.343400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.228600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.896000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.064260E-02 |
| Normal-vs-Grade 2 |
4.41279999999766E-05 |
| Normal-vs-Grade 3 |
2.36180000001696E-06 |
| Normal-vs-Grade 4 |
2.21099999997421E-06 |
| Grade 1-vs-Grade 2 |
2.214200E-01 |
| Grade 1-vs-Grade 3 |
1.096370E-01 |
| Grade 1-vs-Grade 4 |
3.778800E-04 |
| Grade 2-vs-Grade 3 |
5.486400E-01 |
| Grade 2-vs-Grade 4 |
1.282330E-03 |
| Grade 3-vs-Grade 4 |
2.583100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.421910E-04 |
| Normal-vs-ccB subtype |
2.8874000002066E-07 |
| ccA subtype-vs-ccB subtype |
1.278370E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.49869999638486E-08 |
| Normal-vs-N1 |
6.179300E-03 |
| N0-vs-N1 |
6.804400E-02 |
|
|
